凝血因子Ⅴ(F5)多克隆抗体
Polyclonal Antibody to Coagulation Factor V (F5)
FV; FVL; PCCF; Proaccelerin; Labile Factor; Factor V Leiden; Accelerator Globulin; Activated protein C cofactor; Proaccelerin, labile factor
- 编号PAA675Bo01
- 物种Bos taurus; Bovine (Cattle，牛) 相同的名称，不同的物种。
- 来源多抗制备
- 宿主兔
- 效价-
- Ig类型 IgG
- 纯化方式抗原特异性亲和纯化
- 标记物无标记物
- 免疫原 RPA675Bo01-凝血因子Ⅴ(F5)重组蛋白
- 缓冲液成份磷酸盐缓冲液（pH7.4,含有0.02% NaN3和50%甘油）
- 性状液体
- 浓度0.5mg/ml
- 且适物种Homo sapiens (Human，人)
- 应用WB; IHC; ICC; IP.
如果抗体需用于流式细胞术，请参见流式抗体。 - 下载 英文说明书 中文说明书
- 规格 20µl100µl 200µl 1ml 10ml
- 价格 ¥ 680 ¥ 1588 ¥ 2268 ¥ 5670 ¥ 22680
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
-
产品包装(模拟)
-
产品包装(模拟)
-
DAB staining on IHC-P; Sample: Bovine Liver Tissue; Primary Ab: 10ug/ml Rabbit Anti-Bovine F5 Antibody Second Ab: 2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
-
Figure. Western Blot; Sample: Recombinant F5, Bovine.
-
通过ISO 9001、ISO 13485质量体系认证
特异性
该抗体是针对F5的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别F5。
用法
Western blotting: 0.5-2µg/mL
Immunohistochemistry: 5-20µg/mL
Immunocytochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.
储存
经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
赠品
增值服务
相关产品
| 编号 | 适用物种：Bos taurus; Bovine (Cattle，牛) | 应用(仅供研究使用，不用于临床诊断！) |
| RPA675Bo02 | 凝血因子Ⅴ(F5)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA675Bo01 | 凝血因子Ⅴ(F5)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA675Bo02 | 凝血因子Ⅴ(F5)多克隆抗体 | WB; IHC; ICC; IP. |
| PAA675Bo01 | 凝血因子Ⅴ(F5)多克隆抗体 | WB; IHC; ICC; IP. |
| SEA675Bo | 凝血因子Ⅴ(F5)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
参考文献
| 杂志 | 参考文献 |
| Biochem Biophys Res Commun | Thrombin generation in abdominal sepsis is Rho-kinase-dependent [PubMed: 25813486] |
| Cell Transplantation | Evidence of a Pivotal Role for the Distal Part of the Complement Cascade in the Diurnal Release of Hematopoietic Stem Cells Into Peripheral Blood [Pubmed:26087465] |
| Cardiovascular Research | Loss of accelerates arterial thrombosis by increasing formation of neutrophil extracellular traps and plasma tissue factor activity [Pubmed:29444200] |
留言咨询